The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections

Virology Journal

Volumn 10, Issue , 2013, Pages

  Huang, Yuan ^a,b   Wei, Cong ^a   Zheng, Kun ^a   Zhao, Dongchi ^a  

^a WUHAN UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Children; Epstein Barr virus; Primary or post infection

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS CAPSID ANTIGEN;

ARTICLE; BLOOD SAMPLING; CHILD; CHINESE; CLINICAL FEATURE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHUMAN; PETECHIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROLOGY; VIRUS CAPSID;

EID: 84874755706     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-55     Document Type: Article

References (25)

1. Epstein-Barr Virus. Nalesnik MA, Laboratory Diagnosis of Viral Infections New York: Marcel Dekker, Inc, Lennette EH, Smith TF, 1999 85 419
2. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Odumade OA, Hogquist KA, Balfour HH Jr, Clin Microbiol Rev 2011 24 193 209 10.1128/CMR.00044-10 21233512
3. EBV viral load detection in clinical virology. Gärtner B, Preiksaitis JK, J Clin Virol 2010 48 82 90 10.1016/j.jcv.2010.03.016 20395167
4. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. Hess RD, J Clin Microbiol 2004 42 3381 3387 10.1128/JCM.42.8.3381-3387.2004 15297472 (Pubitemid 39045655)
5. A systematic study of Epstein-Barr virus serologic assays following acute infection. Rea TD, Ashley RL, Russo JE, Buchwald DS, Am J Clin Pathol 2002 117 156 161 10.1309/ETK2-L9MG-L6RA-N79Y 11789721 (Pubitemid 34052486)
6. The rational basis for efficient Epstein-Barr virus (EBV) serology. Bauer G, Clin Lab 1995 41 623 634
7. Determination of antibodies directed specifically against Epstein-Barr virus nuclear antigen-1 (EBNA-1) by anticomplementary immunofluorescence (ACIF). Kampmann M, Henninger K, Bauer G, Med Microbiol Lett 1993 2 1 8
8. Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Bauer G, Clin Lab 2001 47 223 230 11405600 (Pubitemid 32492869)
9. Differentiation of primary from secondary anti-EBNA-1-negative cases by determination of avidity of VCA-IgG. Vetter V, Kreutzer L, Bauer G, Clin Diagn Virol 1994 2 29 39 10.1016/0928-0197(94)90033-7 15566751 (Pubitemid 24091444)
10. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A, J Med Virol 2003 70 617 623 10.1002/jmv.10439 12794726 (Pubitemid 36734728)
11. Epstein-Barr virus. Rickinson A, Kieff E, Fields Virology Philadelphia: Lippincott Williams & Wilkins, Knipe D, Howley P, 4 2001 2575 2627
12. Epstein-Barr virus (EBV) infection in infancy. Chan KH, Tam JS, Peiris JS, Seto WH, Ng MH, J Clin Virol 2001 21 57 62 10.1016/S1386-6532(01)00149-4 11255098 (Pubitemid 32194584)
13. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. Kangro HO, Osman HK, Lau YL, Heath RB, Yeung CY, Ng MH, J Med Virol 1994 43 91 96 10.1002/jmv.1890430117 8083655 (Pubitemid 24146351)
14. Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, Mori S, Pathol Int 2006 56 112 116 10.1111/j.1440-1827.2006.01936.x 16497243
15. Correlation between the immunological condition and the results of immunoenzymatic tests in diagnosing infectious mononucleosis. Tamaro G, Donato M, Princi T, Parco S, Acta Biomed 2009 80 47 50 19705620
16. Evaluation of a multiplex flow immunoassay for detection of Epstein-Barr virus-specific antibodies. Binnicker MJ, Jespersen DJ, Harring JA, Rollins LO, Beito EM, Clin Vaccine Immunol 2008 15 1410 1413 10.1128/CVI.00082-08 18632919
17. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants. Dohno S, Maeda A, Ishiura Y, Sato T, Fujieda M, Wakiguchi H, Pediatr Int 2010 52 536 540 10.1111/j.1442-200X.2010.03087.x 20113421
18. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K, J Med Virol 1998 56 186 191 10.1002/(SICI)1096-9071(199811) 56:3<186::AID-JMV2>3.0.CO;2-3 9783683 (Pubitemid 28458083)
19. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Avgil M, Ornoy A, Reprod Toxicol 2006 21 436 445 10.1016/j.reprotox.2004.11.014 16580943
20. Seroepidemiology of EBV and Interpretation of the "Isolated VCA IgG" pattern. De Paschale M, Agrappi C, Manco MT, Mirri P, Viganò EF, Clerici P, J Med Virol 2009 81 325 331 10.1002/jmv.21373 19107979
21. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. Tone WN, Helge M, J Clinl Virol 2007 38 292 297 10.1016/j.jcv.2007.01.006 (Pubitemid 46413995)
22. Epstein-Barr virus associated Infectious mononucleosis in Chinese children. Chan CW, Chiang AK, Chan KH, Lau AS, Pediatr Infect Dis J 2003 22 974 978 10.1097/01.inf.0000095199.56025.96 14614370 (Pubitemid 37445075)
23. Epstein-Barr Virus-recent advances. Macsween KF, Crawford DH, Lancet Infect Dis 2003 3 131 140 10.1016/S1473-3099(03)00543-7 12614729 (Pubitemid 36278122)
24. Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing. Gao LW, Xie ZD, Liu YY, Wang Y, Shen KL, China. World J Pediatr 2011 7 45 49 10.1007/s12519-011-0244-1
25. Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis. Wang X, Yang K, Wei C, Huang Y, Zhao D, Virol J 2010 7 247 10.1186/1743-422X-7-247 20858235